Cardiovascular Risk Management in Dyslipidemia: Clinical

Controversies

Statin Intolerance

PROVE-IT TIMI 22

Familial Hypercholesterolemia

Estimated Rates of FH Diagnoses

LDL Hypothesis

Impact of PCSK9 on LDL Receptor Expression

PCSK9 Inhibitors

Abbreviations

Abbreviations (cont)

References